Related Experiment Video
Updated: May 31, 2026
07:56
Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
[Bone mineral density in patients with type 2 diabetes]
Leobardo Sauque-Reyna1, María Alejandra Salcedo-Parra, Pedro Rafael Sánchez-Vargas
1Unidad Metabólica y Cardiovascular SC de Cuernavaca, Cuernavaca. leobardo_sauque_@hotmail.com
Summary
Type 2 diabetes (T2D) appears to be a protective factor against osteoporosis, particularly in the hip and femoral areas. This finding suggests T2D may independently reduce osteoporosis risk.
Area of Science:
- Endocrinology
- Metabolic Bone Disease
- Geriatric Medicine
Background:
- Type 2 Diabetes (T2D) is a complex metabolic disorder with widespread health implications.
- Osteoporosis, characterized by reduced bone mineral density (BMD), is a significant public health concern, increasing fracture risk.
- The relationship between T2D and bone health, specifically BMD, remains an area of active research.
Purpose of the Study:
- To investigate the association between Type 2 Diabetes (T2D) and bone mineral density (BMD) at the femoral neck, total hip, and lumbar spine.
- To determine if T2D influences the risk of developing osteoporosis.
Main Methods:
- A comparative cross-sectional study involving 450 participants aged 30 and above.
- Participants were divided into two groups: 245 with T2D and 205 without T2D, matched for age.
- Exclusion criteria included conditions and treatments known to affect BMD, such as other forms of diabetes, inflammatory diseases, and specific medications.
Main Results:
- Menopause was significantly associated with hip osteoporosis (OR 4.2).
- Type 2 Diabetes (T2D) demonstrated a protective effect against hip osteoporosis (OR 0.8).
- In premenopausal women, obesity measures were linked to hip and femoral osteoporosis, while T2D remained protective.
Conclusions:
- Type 2 Diabetes (T2D) is identified as an independent protective factor for osteoporosis.
- The findings suggest a potential benefit of T2D in mitigating osteoporosis risk, particularly in specific skeletal sites.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...